These authors are joint senior authors.
Immunity to infection
Elevated effector cell sensitivity to Treg-cell suppression that is not associated with reduced Th17-cell expression distinguishes HIV+ asymptomatic subjects from progressors
Version of Record online: 2 DEC 2011
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
European Journal of Immunology
Volume 42, Issue 1, pages 138–146, January 2012
How to Cite
Thorborn, G. S., Pomeroy, L., Ishohanni, H., Peters, B. S. and Vyakarnam, A. (2012), Elevated effector cell sensitivity to Treg-cell suppression that is not associated with reduced Th17-cell expression distinguishes HIV+ asymptomatic subjects from progressors. Eur. J. Immunol., 42: 138–146. doi: 10.1002/eji.201141426
- Issue online: 29 DEC 2011
- Version of Record online: 2 DEC 2011
- Accepted manuscript online: 17 OCT 2011 03:55AM EST
- Manuscript Accepted: 6 OCT 2011
- Manuscript Revised: 6 SEP 2011
- Manuscript Received: 17 JAN 2011
- Gilead Pharmaceuticals
- National Institute for Health Research (NIHR)
- NHS Foundation Trust
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.